These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 27430248)

  • 41. [Inducement effect of ginsenoside Rg3 on apoptosis of human bladder transitional cell carcinoma cell line EJ].
    Chen JX; Peng HM; Pu SP; Guo YP
    Zhongguo Zhong Yao Za Zhi; 2007 Aug; 32(16):1680-4. PubMed ID: 18027667
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Protective effect of ginsenoside Rg1 again PC-12 cells in OGD injury through mTOR/Akt/FoxO3 signaling pathway].
    Yan JP; Shen NE; Ye Q; Zong YH; Fang QX; Lv LZ
    Zhongguo Zhong Yao Za Zhi; 2015 Apr; 40(8):1554-9. PubMed ID: 26281597
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Protective effect of ginsenoside Rg3 on lung injury in diabetic rats.
    Wang H; Wu W; Wang G; Xu W; Zhang F; Wu B; Tian Y
    J Cell Biochem; 2019 Mar; 120(3):3323-3330. PubMed ID: 30362612
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antitumor activity of ginsenoside Rg3 in melanoma through downregulation of the ERK and Akt pathways.
    Meng L; Ji R; Dong X; Xu X; Xin Y; Jiang X
    Int J Oncol; 2019 Jun; 54(6):2069-2079. PubMed ID: 31081060
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Plumbagin induces G2/M arrest, apoptosis, and autophagy via p38 MAPK- and PI3K/Akt/mTOR-mediated pathways in human tongue squamous cell carcinoma cells.
    Pan ST; Qin Y; Zhou ZW; He ZX; Zhang X; Yang T; Yang YX; Wang D; Qiu JX; Zhou SF
    Drug Des Devel Ther; 2015; 9():1601-26. PubMed ID: 25834400
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Knockdown of DEPTOR inhibits cell proliferation and increases chemosensitivity to melphalan in human multiple myeloma RPMI-8226 cells via inhibiting PI3K/AKT activity.
    Zhang HR; Chen JM; Zeng ZY; Que WZ
    J Int Med Res; 2013 Jun; 41(3):584-95. PubMed ID: 23613505
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ginsenoside Rg3 regulates DNA damage in non-small cell lung cancer cells by activating VRK1/P53BP1 pathway.
    Liu T; Zuo L; Guo D; Chai X; Xu J; Cui Z; Wang Z; Hou C
    Biomed Pharmacother; 2019 Dec; 120():109483. PubMed ID: 31629252
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Discovery of chrysoeriol, a PI3K-AKT-mTOR pathway inhibitor with potent antitumor activity against human multiple myeloma cells in vitro.
    Yang Y; Zhou X; Xiao M; Hong Z; Gong Q; Jiang L; Zhou J
    J Huazhong Univ Sci Technolog Med Sci; 2010 Dec; 30(6):734-40. PubMed ID: 21181363
    [TBL] [Abstract][Full Text] [Related]  

  • 49. MK2206 enhances the cytocidal effects of bufalin in multiple myeloma by inhibiting the AKT/mTOR pathway.
    Xiang RF; Wang Y; Zhang N; Xu WB; Cao Y; Tong J; Li JM; Wu YL; Yan H
    Cell Death Dis; 2017 May; 8(5):e2776. PubMed ID: 28492559
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antitumor effects of ginsenoside Rg3 on human hepatocellular carcinoma cells.
    Zhang C; Liu L; Yu Y; Chen B; Tang C; Li X
    Mol Med Rep; 2012 May; 5(5):1295-8. PubMed ID: 22366885
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Combination of ginsenoside Rg3 with docetaxel enhances the susceptibility of prostate cancer cells via inhibition of NF-kappaB.
    Kim SM; Lee SY; Cho JS; Son SM; Choi SS; Yun YP; Yoo HS; Yoon DY; Oh KW; Han SB; Hong JT
    Eur J Pharmacol; 2010 Apr; 631(1-3):1-9. PubMed ID: 20056115
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The phosphatidylinositol 3-kinase/AKT kinase pathway in multiple myeloma plasma cells: roles in cytokine-dependent survival and proliferative responses.
    Tu Y; Gardner A; Lichtenstein A
    Cancer Res; 2000 Dec; 60(23):6763-70. PubMed ID: 11118064
    [TBL] [Abstract][Full Text] [Related]  

  • 53. AKT serine/threonine protein kinase modulates bufalin-triggered intrinsic pathway of apoptosis in CAL 27 human oral cancer cells.
    Tsai SC; Lu CC; Lee CY; Lin YC; Chung JG; Kuo SC; Amagaya S; Chen FN; Chen MY; Chan SF; Yang JS
    Int J Oncol; 2012 Nov; 41(5):1683-92. PubMed ID: 22922805
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Danusertib Induces Apoptosis, Cell Cycle Arrest, and Autophagy but Inhibits Epithelial to Mesenchymal Transition Involving PI3K/Akt/mTOR Signaling Pathway in Human Ovarian Cancer Cells.
    Zi D; Zhou ZW; Yang YJ; Huang L; Zhou ZL; He SM; He ZX; Zhou SF
    Int J Mol Sci; 2015 Nov; 16(11):27228-51. PubMed ID: 26580601
    [TBL] [Abstract][Full Text] [Related]  

  • 55. 20(s)-ginsenoside Rg3 promotes apoptosis in human ovarian cancer HO-8910 cells through PI3K/Akt and XIAP pathways.
    Wang JH; Nao JF; Zhang M; He P
    Tumour Biol; 2014 Dec; 35(12):11985-94. PubMed ID: 25168366
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Induction of G2/M phase cell cycle arrest and apoptosis by ginsenoside Rf in human osteosarcoma MG‑63 cells through the mitochondrial pathway.
    Shangguan WJ; Li H; Zhang YH
    Oncol Rep; 2014 Jan; 31(1):305-13. PubMed ID: 24173574
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pivotal Roles of Ginsenoside Rg3 in Tumor Apoptosis Through Regulation of Reactive Oxygen Species.
    Sun HY; Lee JH; Han YS; Yoon YM; Yun CW; Kim JH; Song YS; Lee SH
    Anticancer Res; 2016 Sep; 36(9):4647-54. PubMed ID: 27630307
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ginsenoside Rg3 inhibits colorectal tumor growth via down-regulation of C/EBPβ/NF-κB signaling.
    Yang X; Zou J; Cai H; Huang X; Yang X; Guo D; Cao Y
    Biomed Pharmacother; 2017 Dec; 96():1240-1245. PubMed ID: 29169725
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Research on the antitumor effect of ginsenoside Rg3 in B16 melanoma cells.
    Chen J; Peng H; Ou-Yang X; He X
    Melanoma Res; 2008 Oct; 18(5):322-9. PubMed ID: 18781130
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Nitidine chloride inhibits proliferation, induces apoptosis via the Akt pathway and exhibits a synergistic effect with doxorubicin in ovarian cancer cells.
    Ding F; Liu T; Yu N; Li S; Zhang X; Zheng G; Lv C; Mou K; Xu J; Li B; Wang S; Song H
    Mol Med Rep; 2016 Sep; 14(3):2853-9. PubMed ID: 27485415
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.